DISPOSITION OF PENTOPRIL, A NEW ORALLY ACTIVE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, AND ITS ACTIVE METABOLITE IN RATS

被引:7
作者
RAKHIT, A
KOCHAK, G
DOTSON, R
TIPNIS, V
机构
关键词
D O I
10.1002/jps.2600740908
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:947 / 952
页数:6
相关论文
共 13 条
[1]   ENALAPRIL MALEATE AND A LYSINE ANALOG (MK-521) IN NORMAL VOLUNTEERS - RELATIONSHIP BETWEEN PLASMA DRUG LEVELS AND THE RENIN-ANGIOTENSIN SYSTEM [J].
BIOLLAZ, J ;
SCHELLING, JL ;
COMBES, BJD ;
BRUNNER, DB ;
DESPONDS, G ;
BRUNNER, HR ;
ULM, EH ;
HICHENS, M ;
GOMEZ, HJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :363-368
[2]   EFFECT OF A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK 421 AND ITS LYSINE ANALOG ON THE COMPONENTS OF THE RENIN SYSTEM IN HEALTHY-SUBJECTS [J].
BRUNNER, DB ;
DESPONDS, G ;
BIOLLAZ, J ;
KELLER, I ;
FERBER, F ;
GAVRAS, H ;
BRUNNER, HR ;
SCHELLING, JL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (05) :461-467
[3]  
BUSH ED, UNPUB CIBA GEIGY
[4]  
CHEN DS, 1984, CURR THER RES CLIN E, V35, P253
[5]  
DESCOMBES BJ, 1983, J CARDIOVASC PHARM, V5, P511
[6]   ANTIHYPERTENSIVE EFFECT OF ORAL ANGIOTENSIN CONVERTING-ENZYME INHIBITOR SQ 14225 IN MAN [J].
GAVRAS, H ;
BRUNNER, HR ;
TURINI, GA ;
KERSHAW, GR ;
TIFFT, CP ;
CUTTELOD, S ;
GAVRAS, I ;
VUKOVICH, RA ;
MCKINSTRY, DN .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (18) :991-995
[7]   UNDERSTANDING THE DOSE-EFFECT RELATIONSHIP - CLINICAL-APPLICATION OF PHARMACOKINETIC-PHARMACODYNAMIC MODELS [J].
HOLFORD, NHG ;
SHEINER, LB .
CLINICAL PHARMACOKINETICS, 1981, 6 (06) :429-453
[8]  
METZLER CM, 1974, BIOMETRICS, V30, P562
[9]  
RAKHIT A, 1984, CLIN CHEM, V30, P1237
[10]  
TOCCO DJ, 1982, DRUG METAB DISPOS, V10, P15